CD163 and atherosclerosis: A recent study found that CD163+ macrophages promoted plaque angiogenesis, vascular permeability, inflammation, and progression of atherosclerosis, and deletion of CD163 in mice reduced intraplaque neovascularization and plaque progression (Guo et al., 2018).